Infertility: Clinical Trials

49 trials for Infertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 unknown. 49 Phase 2, 12 Phase 1, 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 249Unknown 49
Phase 112Unknown 12
Phase 39Unknown 9

Follow Infertility: new trials by email Literature Review of Infertility trials Research Report on Infertility

Trials (filtered) newest first · largest first

All 49 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
Double trigger, HCG trigger - Infertility
Phase 2UnknownBedaya Hospital1502023-12-302023-11-29
Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
Lutropin alfa, Human chorionic gonadotropin - Acquired Hypogonadotropic Hypogonadism
Phase 2UnknownAzienda Ospedaliero-Universitaria di Modena322022-01-192023-07-20
Testing a New Self-help Intervention for Infertility Related Distress: a Pilot Study
Coping with Infertility Program - Infertility, Female
Phase 1 / Phase 2UnknownUniversity of Regina202021-11-012022-02-01
Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility
Tab Tamoxifen 10 mg, Tab Tamoxifen 10mg,Cap vitamin E 400mg - Oligoasthenoteratozoospermia, Male Infertility
Phase 2UnknownSharif Medical Research Center1102021-10-152022-01-21
A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle
progesterone - Infertility
Phase 2UnknownNanjing University9002021-07-012021-06-24
Double Trigger in Patients With Low Proportion of Mature Oocytes
Double trigger, HCG trigger - Infertility, Female
Phase 2UnknownRiyadh Fertility and Reproductive Health center662020-05-302020-05-29
Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles
Double trigger, HCG trigger - Infertility, Female
Phase 2UnknownRiyadh Fertility and Reproductive Health center562020-05-302020-05-29
G-CSF and PRP in Patients With Recurrent Implantation Failure
Granulocyte colony-stimulating factor and platelet-rich plasma group, Control group - Infertility,Female
Phase 2UnknownRiyadh Fertility and Reproductive Health center1122020-05-282020-06-02
Clinical Study of in Situ Regeneration of Endometrium
CBD-bFGF, Collagen/BMMNCs, Estrogen - Infertility, Female, of Uterine Origin, Endometrial Fibrosis
Phase 1 / Phase 2UnknownYali Hu3452020-04-292022-09-28
Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial
Myo-inositol - Poor Ovarian Response
Phase 2 / Phase 3UnknownAmerican University of Beirut Medical Center2262020-02-112020-02-18
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
Gonadotropin-releasing hormone agonist - Infertility
Phase 2UnknownKuban State Medical University1022020-01-202021-12-03
Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
placebo, metformin, Sitagliptin - Polycystic Ovary Syndrome, Infertility
Phase 1 / Phase 2UnknownShahid Beheshti University of Medical Sciences802020-01-102021-03-22
A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore
Mirena, Megace - Endometrial Hyperplasia, Fertility Issues
Phase 2UnknownKK Women's and Children's Hospital602020-01-032022-08-08
Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response
PRP - Infertility
Phase 2UnknownNanjing University502019-07-202021-11-03
Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility
Clomiphene Citrate 50mg, Cabergoline Oral Tablet, Placebo Oral Tablet - Infertility
Phase 2 / Phase 3UnknownAssiut University1202018-07-012018-06-08
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
GnRH ant/letrozole, GnRH ant - Infertility
Phase 2UnknownCairo University1062018-04-012020-02-13
Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility
Lipoaspiration and SVF introduction., Standard therapy. - Azoospermia, Oligozoospermia
Phase 2UnknownState-Financed Health Facility "Samara Regional Medical Center Dinasty"402018-03-122020-10-22
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota
Clindamycin, Placebo - Bacterial Vaginoses, Infertility, Female
Phase 2UnknownPeter Humaidan3332017-12-072023-07-06
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
Growth hormone/HPuFSH/GnRH antagonist, HPuFSH/GnRH antagonist - Infertility, Female
Phase 2UnknownRiyadh Fertility and Reproductive Health center2282017-11-292020-05-27
Open Label Immunotherapy of Endometriosis
V-Endo - Endometriosis
Phase 2UnknownImmunitor LLC302017-10-012019-04-16

Showing 20 of 49. Sign in to see all of them.

Narrower conditions

Infertility, Female (14)  ·  Infertility, Male (5)  ·  Azoospermia (3)  ·  Oligospermia (3)  ·  Endometriosis (2)  ·  Hypogonadism (2)  ·  Polycystic Ovary Syndrome (2)  ·  Abortion, Spontaneous (1)  ·  Amenorrhea (1)  ·  Anxiety Disorders (1)  ·  Asthenozoospermia (1)  ·  Autoimmune Diseases (1)  ·  Azoospermia, Nonobstructive (1)  ·  Depression (1)

Broader conditions

Genital Diseases (49)  ·  Urogenital Diseases (49)  ·  Female Urogenital Diseases and Pregnancy Complications (21)  ·  Female Urogenital Diseases (20)  ·  Genital Diseases, Female (19)  ·  Male Urogenital Diseases (7)  ·  Genital Diseases, Male (6)  ·  Endocrine System Diseases (4)  ·  Gonadal Disorders (4)  ·  Adnexal Diseases (2)  ·  Cysts (2)  ·  Neoplasms (2)  ·  Ovarian Cysts (2)  ·  Ovarian Diseases (2)

Interventions

Cabergoline (3)  ·  Gonadotropin-Releasing Hormone (3)  ·  Chorionic Gonadotropin (2)  ·  Clomiphene (2)  ·  Gonadotropins (2)  ·  Luteinizing Hormone, beta Subunit (2)  ·  Metformin (2)  ·  Triptorelin Pamoate (2)  ·  cetrorelix (2)  ·  follitropin alfa (2)  ·  Clindamycin (1)  ·  Collagen (1)  ·  Control Groups (1)  ·  Coping Skills (1)  ·  Diet Therapy (1)

Sponsors

Ain Shams University (4)  ·  Riyadh Fertility and Reproductive Health center (4)  ·  Assiut University (2)  ·  Benha University (2)  ·  Kasr El Aini Hospital (2)  ·  Nanjing University (2)  ·  Reprogenetics (2)  ·  University of Athens (2)  ·  A.O.U. Città della Salute e della Scienza (1)  ·  Aljazeera Hospital (1)  ·  American University of Beirut Medical Center (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Azienda Ospedaliero-Universitaria di Modena (1)  ·  Bedaya Hospital (1)  ·  Cairo University (1)

Countries

Egypt (17)  ·  China (7)  ·  United States (3)  ·  Iran (2)  ·  Italy (2)  ·  Russia (2)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Greece (1)  ·  Israel (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Mongolia (1)  ·  Pakistan (1)

Top investigators

Usama M Fouda, Prof. (4)  ·  Santiago Munne, PhD (2)  ·  Ahmed A Wali, M.D, PhD (1)  ·  Ahmed Abbas, MD (1)  ·  Ahmed M Kamel, MD (1)  ·  Aldo Maina, MD (1)  ·  Anees Fatima, MBBS,FCPS (1)  ·  Antoine Abu Mussa, MD (1)  ·  Ashraf Moieni, MD (1)  ·  Bing Yao, MD (1)  ·  Dina M Dakhly, MD (1)  ·  Eduardo LA Motta, MD, PhD (1)  ·  Efstratios Kolibianakis, MD, MSc, PhD (1)  ·  Fatemeh Zafarani, MSc (1)  ·  Fatma Faisel, M.D, PhD (1)

Results publications

PMID 11228933, PMID 12516764, PMID 19381855, PMID 22081410, PMID 22459631, PMID 23292545, PMID 23341491, PMID 23757979, PMID 25274200, PMID 25456165, PMID 25904960, PMID 27184139, PMID 28139240, PMID 29132339, PMID 30243299, PMID 31710189, PMID 31997236, PMID 32034419, PMID 32720198, PMID 32898291, PMID 33539543, PMID 33851429, PMID 34808697, PMID 36536470, PMID 39152484, PMID 39215793, PMID 8973665

NIH funding

U54HD028138 (1)